Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Cytos Biotechnology AG

+ Add to Watchlist

CYTN:SW

1.03 CHF 0.14 11.97%

As of 05:01:44 ET on 05/07/2015.

Company Profile for Cytos Biotechnology AG (CYTN)

Cytos Biotechnology AG develops and produces biopharmaceuticals. The Company produces vaccines that immunize the patient against disease related proteins. This instructs the immune system to produce antibodies to reverse or prevent disease progression. Cytos develops treatments for immunology and inflammation disorders, cancer and cardiovascular, nervous system, and infectious diseases.

Contact Information

Cytos Biotechnology AG

Wagistrasse 25
Postfach
Schlieren, 8952
Switzerland
Phone: 41-44-733-4747
Fax: 41-44-733-4740

Key Executives for Cytos Biotechnology AG (CYTN)

Christian ItinChairman/CEOHarry WeltenExec VP/CFO
Frank HenneckeExec VP:Product DevDorothee KrumwiehVice President
Cheryl LassenVP:Clinical DevelopmentMartin SperrleVP:Intellectual Property
Philippe SaudanVP:Research & Preclinical Dev

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil